2023 annual financial data
Nektar Therapeutics 2023 Net income
Direct answer
Net income was -276,056,000 USD.
Operating income was -137,425,000 USD and net income was -276,056,000 USD.
Operating cash flow was -192,606,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 90,122,000 USD
- Operating income
- -137,425,000 USD
- Net income
- -276,056,000 USD
- Operating cash flow
- -192,606,000 USD